More General News
View Older Stories View Newer Stories-
Testing times: More work needed on Astra/Oxford vaccine trials
-
Pfizer CEO confident of getting U.S. advisory panel nod for COVID-19 vaccine
-
Apple could block apps that don't comply with new privacy feature
-
GE to prepay pensions, repay loan in latest debt reduction move
-
Marvell introduces chips for open-source 5G networking gear
-
Apple launches $549 new AirPods Max to boost holiday sales; delivery times face delays
-
U.S. third-quarter productivity pared; unit labor costs revised up
-
American expands preflight testing to all U.S. destinations with travel restrictions
-
Pfizer COVID-19 vaccine data wins backing of U.S. FDA staff, authorization nears
-
Musk's SpaceX scrubs key high-altitude Starship test
-
Philippines receives $29 million of military equipment from U.S. to boost defences
-
Wall Street closes higher on vaccine lift; S&P 500, Nasdaq at records
-
In COVID-19 milestone for West, Britain starts mass vaccination
-
Tesla launches second $5 billion share sale in three months
-
Consumer spending, exports drive euro zone growth to record high
-
Good luck finding a PlayStation 5: Walmart and other retailers battle ‘bots’ snatching up hot products
-
FCC awards $9.2 billion to deploy broadband to 5.2 million U.S. homes, businesses
-
Palantir wins $44 million FDA contract, boosting shares 21%
-
Tesla's Musk moves private foundation to Texas
-
New York Reports 7,302 New Virus Cases
-
Some States' Covid Vaccine Estimates Used Outdated Figures, Assume for Pfizer (PFE) Shots Would be Available: HHS - Bloomberg
-
Exxon faces proxy fight launched by new activist firm Engine No. 1
-
Fauci Warns of Surge Upon Surge During Holidays, Things Could Get Really Bad Mid-January
-
Robinhood restores service amid wider trading outages
-
Comcast's (CMCSA) Sky is Said to Weigh Cutting up to 20% of Italy Staff - Bloomberg
-
U.S. slaps sanctions on 14 Chinese officials over Hong Kong crackdown
-
U.S. AstraZeneca vaccine trial will clear confusion on how well it works: U.S. scientist
-
Robinhood Reports Service Disruption - Bloomberg
-
Airbnb streamlines fees as it tilts toward biggest hosts
-
Billionaire Siebel's C3.ai boosts IPO price range as investors flock to tech stocks
-
Californians endure another lockdown as COVID-19 patients overwhelm hospitals
-
Paysafe to go public in Bill Foley-backed $9 billion deal
-
Thiel-backed therapy developer AbCellera looks to raise up to $391 million in IPO
-
Nasdaq closes at record high as growth names get a lift
-
Capital One stops 'risky' buy-now-pay-later credit card transactions
-
Goldman mulls Florida base for asset management arm: Bloomberg News
-
San Francisco Bay Area to Impose Shelter-at-Home Rules - Bloomberg
-
Five worrying takeaways from Friday's U.S. jobs report
-
New York Reports 11,271 New Virus Cases
-
Fed Chair Powell held flurry of calls with Mnuchin in October
-
California Reports Record 22,018 New Coronavirus Cases - Bloomberg
-
Drug industry trade groups sue Trump admin over drug pricing rule
-
U.S. COVID-19 relief talks gain momentum as lawmakers set Monday deadline
-
Fed's Evans: comfortable with current bond-buying, not opposed to more easing
-
ECB Urged to Extend Bank Dividend Ban Six Months by Watchdog - Bloomberg
-
U.S. factory orders increase more than expected in October
-
Boeing again cutting widebody production rate
-
Wall St. opens near record highs as grim jobs data fuels stimulus hopes
-
Take Five: The clocks are ticking down
-
American Airlines sees fourth-quarter cash burn at high end of guidance
